Rosemary (Rosmarinus officinalis L.) Leaf Extract Limits Weight Gain and Liver Steatosis in Mice Fed a High-Fat Diet

Abstract

The objective of this study was to investigate the effects of rosemary (Rosmarinus officinalis L.) leaf extract (RE) on the prevention of weight gain and associated metabolic disorders in mice fed a high-fat diet. For this purpose, RE was administered for 50 days at 20 or 200 mg/kg body weight (BW) to mice fed a high-fat diet. Body weight was monitored during the study and body composition was measured before and at the end of the intervention. Glucose tolerance, assessed by an intraperitoneal glucose tolerance test (IPGTT), and hepatic and faecal lipid contents were determined at the end of the study. Treatment with 200 mg/kg BW of RE induced a significant reduction of weight and fat mass gain (− 64 % and − 57 %, respectively) associated with an increase of faecal lipid excretion. This effect appears to be related to the inhibition of pancreatic lipase activity induced by RE, as demonstrated in vitro. While glucose tolerance and fasting glycaemia were not affected by RE treatment, hepatic triglyceride levels were decreased by 39 % in RE-treated mice. Administration of the lower dose of RE (20 mg/kg BW) was ineffective on all the parameters measured. In conclusion, our results demonstrate that consumption of 200 mg/kg BW of RE can limit weight gain induced by a high-fat diet and protect against obesity-related liver steatosis.

Rosmarinus officinalis L. - Lamiaceae - glucose tolerance - lipase - weight control

References

• 1 al-Sereiti M R, Abu-Amer K M, Sen P. Pharmacology of rosemary (Rosmarinus officinalis Linn.) and its therapeutic potentials.  Indian J Exp Biol. 1999;  37 124-130
• 2 Peng Y, Yuan J, Liu F, Ye J. Determination of active components in rosemary by capillary electrophoresis with electrochemical detection.  J Pharm Biomed Anal. 2005;  39 431-437
• 3 Frankel E N, Huang S W, Aeschbach R, Prior E. Antioxidant activity of a rosemary extract and its constituents, carnosic acid carnosol and rosmarinic acid in bulk oil and oil-in-water emulsion.  J Agric Food Chem. 1996;  44 131-135
• 4 Poeckel D, Greiner C, Verhoff M, Rau O, Tausch L, Hornig C, Steinhilber D, Schubert-Zsilavecz M, Werz O. Carnosic acid and carnosol potently inhibit human 5-lipoxygenase and suppress pro-inflammatory responses of stimulated human polymorphonuclear leukocytes.  Biochem Pharmacol. 2008;  76 91-97
• 5 Zeng H H, Tu P F, Zhou K, Wang H, Wang B H, Lu J F. Antioxidant properties of phenolic diterpenes from Rosmarinus officinalis.  Acta Pharmacol Sin. 2001;  22 1094-1098
• 6 Johnson J J, Syed D N, Heren C R, Suh Y, Adhami V M, Mukhtar H. Carnosol, a dietary diterpene, displays growth inhibitory effects in human prostate cancer PC3 cells leading to G2-phase cell cycle arrest and targets the 5′-AMP-activated protein kinase (AMPK) pathway.  Pharm Res. 2008;  25 2125-2134
• 7 Ninomiya K, Matsuda H, Shimoda H, Nishida N, Kasajima N, Yoshino T, Morikawa T, Yoshikawa M. Carnosic acid, a new class of lipid absorption inhibitor from sage.  Bioorg Med Chem Lett. 2004;  14 1943-1946
• 8 Rau O, Wurglics M, Paulke A, Zitzkowski J, Meindl N, Bock A, Dingermann T, Abdel-Tawab M, Schubert-Zsilavecz M. Carnosic acid and carnosol, phenolic diterpene compounds of the labiate herbs rosemary and sage, are activators of the human peroxisome proliferator-activated receptor gamma.  Planta Med. 2006;  72 881-887
• 9 Rosen E D, Spiegelman B M. PPARgamma: a nuclear regulator of metabolism, differentiation, and cell growth.  J Biol Chem. 2001;  276 37731-37734
• 10 Wagstaff A J, Goa K L. Spotlight on rosiglitazone in the management of type 2 diabetes mellitus.  Treat Endocrinol. 2002;  1 411-414
• 11 Bakirel T, Bakirel U, Keles O U, Ulgen S G, Yardibi H. In vivo assessment of antidiabetic and antioxidant activities of rosemary (Rosmarinus officinalis) in alloxan-diabetic rabbits.  J Ethnopharmacol. 2008;  116 64-73
• 12 Samman S, Sandstrom B, Toft M B, Bukhave K, Jensen M, Sorensen S S, Hansen M. Green tea or rosemary extract added to foods reduces nonheme-iron absorption.  Am J Clin Nutr. 2001;  73 607-612
• 13 Folch J, Lees M, Sloane Stanley G H. A simple method for the isolation and purification of total lipides from animal tissues.  J Biol Chem. 1957;  226 497-509
• 14 Jeejeebhoy K N, Ahmad S, Kozak G. Determination of fecal fats containing both medium and long chain triglycerides and fatty acids.  Clin Biochem. 1970;  3 157-163
• 15 Guerciolini R. Mode of action of orlistat.  Int J Obes Relat Metab Disord. 1997;  21 (Suppl. 3) S12-S23
• 16 Karu N, Reifen R, Kerem Z. Weight gain reduction in mice fed Panax ginseng saponin, a pancreatic lipase inhibitor.  J Agric Food Chem. 2007;  55 2824-2828
• 17 Tsujita T, Takaichi H, Takaku T, Aoyama S, Hiraki J. Antiobesity action of epsilon-polylysine, a potent inhibitor of pancreatic lipase.  J Lipid Res. 2006;  47 1852-1858
• 18 Yamamoto M, Shimura S, Itoh Y, Ohsaka T, Egawa M, Inoue S. Anti-obesity effects of lipase inhibitor CT-II, an extract from edible herbs, Nomame Herba, on rats fed a high-fat diet.  Int J Obes Relat Metab Disord. 2000;  24 758-764
• 19 Zelber-Sagi S, Kessler A, Brazowsky E, Webb M, Lurie Y, Santo M, Leshno M, Blendis L, Halpern Z, Oren R. A double-blind randomized placebo-controlled trial of orlistat for the treatment of nonalcoholic fatty liver disease.  Clin Gastroenterol Hepatol. 2006;  4 639-644
• 20 Sotelo-Felix J I, Martinez-Fong D, Muriel P, Santillan R L, Castillo D, Yahuaca P. Evaluation of the effectiveness of Rosmarinus officinalis (Lamiaceae) in the alleviation of carbon tetrachloride-induced acute hepatotoxicity in the rat.  J Ethnopharmacol. 2002;  81 145-154
• 21 Fahim F A, Esmat A Y, Fadel H M, Hassan K F. Allied studies on the effect of Rosmarinus officinalis L. on experimental hepatotoxicity and mutagenesis.  Int J Food Sci Nutr. 1999;  50 413-427
• 22 Hoffler U, Hobbie K, Wilson R, Bai R, Rahman A, Malarkey D, Travlos G, Ghanayem B I. Diet-induced obesity is associated with hyperleptinemia, hyperinsulinemia, hepatic steatosis, and glomerulopathy in C57Bl/6J mice.  Endocrine. 2009;  36 311-325